# Altman Z-Score Analysis Report: Clover Health Investments, Corp (CLOV)

---
## Introduction
This report provides a comprehensive, theory-informed financial health analysis of the selected company using the Altman Z-Score framework. It integrates quantitative diagnostics, turnaround management theory, and stakeholder recommendations, with all findings and recommendations grounded in referenced academic and industry sources. The analysis is generated by an expert LLM-driven pipeline, ensuring transparency, reproducibility, and robust source attribution.

**Author:** Fabio Correa

**Source Attribution:** This report and analysis pipeline are generated using the open-source Altman Z-Score Analysis project, available at [https://github.com/fabioc-aloha/Altman-Z-Score](https://github.com/fabioc-aloha/Altman-Z-Score).

**License:** This software is distributed under the Attribution Non-Commercial License (MIT-based). See the LICENSE file for details.

Disclaimer: The developer disclaims any responsibility for the accuracy, completeness, or consequences of the analysis and information provided by this software. All results are for informational purposes only and should not be relied upon for financial, investment, or legal decisions.
---

**Script Version:** v2.7.1

## Analysis Context and Z-Score Model Selection Criteria

- **Industry:** SIC 6324 (SIC 6324)
- **Ticker:** CLOV
- **Public:** True
- **Emerging Market:** False
- **Maturity:** Mature Company
- **Model:** Zʺ-Score (Public Non-Manufacturing, 1995) (service)
- **Analysis Date:** 2025-06-03

## Z-Score Formula Used

Z = 6.56*X1 + 3.26*X2 + 6.72*X3 + 1.05*X4
- X1 = (Current Assets - Current Liabilities) / Total Assets
- X2 = Retained Earnings / Total Assets
- X3 = EBIT / Total Assets
- X4 = Equity / Total Liabilities

**Thresholds:**
- Safe Zone: > 2.90
- Grey Zone: > 1.23 and <= 2.90
- Distress Zone: <= 1.23



---

# Graphical View of the Z-Score Analysis


![Z-Score and Price Trend Chart](zscore_CLOV_trend.png)

*Figure: Z-Score and stock price trend for CLOV (image not available yet; will be generated after analysis)*


## Z-Score Component Table (by Quarter)
| Quarter   |    X1 |     X2 |     X3 |    X4 |   Z-Score | Diagnostic    | Consistency Warning   |
|-----------|-------|--------|--------|-------|-----------|---------------|-----------------------|
| 2025 Q1   | 0.198 | -3.776 | -0.002 | 6.038 |    -4.683 | Distress Zone | No issues             |
| 2024 Q4   | 0.223 | -3.793 | -0.037 | 5.476 |    -5.4   | Distress Zone | No issues             |
| 2024 Q3   | 0.234 | -3.339 | -0.013 | 3.779 |    -5.471 | Distress Zone | No issues             |
| 2024 Q2   | 0.334 | -3.221 |  0.011 | 1.467 |    -6.699 | Distress Zone | No issues             |
| 2024 Q1   | 0.292 | -3.244 | -0.033 | 0.872 |    -7.965 | Distress Zone | No issues             |
# Altman Z-Score Analysis Report: Clover Health Investments, Corp (CLOV)

---

## Company Profile

Clover Health Investments, Corp. is a healthcare technology company based in Jersey City, NJ, primarily focused on providing Medicare Advantage plans. The company operates in the highly competitive healthcare sector, where it competes with other health insurance providers such as UnitedHealth Group, Humana, and Anthem. Clover Health differentiates itself through its innovative use of technology, particularly its Clover Assistant platform, which aims to enhance patient care and streamline healthcare services.

The leadership team is composed of experienced executives, including Mr. Vivek Garipalli (Co-Founder & Executive Chairman), Mr. Andrew Toy (Co-Founder, CEO & Director), and Mr. Peter J. Kuipers (Chief Financial Officer). Other notable executives include Ms. Jamie L. Reynoso (CEO of Medicare Advantage) and Mr. Brady Priest (CEO of Home Care). The team has seen significant compensation events, with Mr. Toy earning approximately $1.58 million, reflecting the company's commitment to retaining top talent in a competitive industry.

---

## 1. Diagnostic Evaluation of Financial Health

Clover Health's financial health is currently in the **Distress Zone**, as indicated by a Z-Score of -4.683. This score suggests severe financial instability, characterized by the following:

- **Liquidity:** The current ratio (X1) is 0.198, indicating that current assets are insufficient to cover current liabilities. This poses a significant liquidity risk.
- **Profitability:** The retained earnings (X2) are negative, reflecting accumulated losses, which is detrimental to the company's long-term viability.
- **Capital Efficiency:** The EBIT (X3) is also negative, suggesting that the company is not generating sufficient earnings from its assets.
- **Leverage:** The equity to total liabilities ratio (X4) is 6.038, indicating a high level of leverage, but this is not sufficient to offset the other negative indicators.

The trajectory of the Z-Score has consistently remained in the Distress Zone over the past several quarters, indicating a persistent risk of bankruptcy if corrective actions are not taken immediately.

---

## 2. Turnaround & Renewal Theory Application

Given the company's status in the **Distress Zone**, an urgent retrenchment strategy is necessary. This involves:

- **Cash Preservation:** Immediate measures should be taken to conserve cash, including reducing operational costs and delaying non-essential expenditures.
- **Creditor Negotiations:** Engage with creditors to restructure debt obligations and seek favorable terms to alleviate financial pressure.

Relevant theoretical frameworks include Hofer's (1980) turnaround sequencing, which emphasizes the importance of stabilizing cash flow before pursuing growth strategies. Bibeault (1999) highlights the need for a clear recovery plan, while Hoskisson et al. (2004) suggest strategic restructuring to improve operational efficiency.

---

## 3. Internal Stakeholder Recommendations

| Title/Role | Responsibilities | Key Performance Metrics | Recommended Actions (Cited) |
| ---------- | ---------------- | ---------------------- | --------------------------- |
| CEO & Executive Leadership | Strategic vision, operational execution | Cash flow, operational efficiency | Implement immediate cost-cutting measures, focus on core operations |
| CFO & Finance Team | Financial stewardship, risk management | Liquidity ratios, debt levels | Negotiate with creditors, develop a cash flow forecast |
| CMO | Domain-specific leadership | Customer satisfaction, retention rates | Enhance customer engagement strategies to retain members |
| Board Members | Oversight and governance | Compliance, strategic alignment | Ensure transparency in financial reporting and strategic decisions |
| Employees | Organizational roles and teams | Employee engagement, productivity | Communicate openly about financial challenges and involve teams in cost-saving initiatives |
| Shareholders | Investment community relations | Share price, investor sentiment | Provide regular updates on financial health and turnaround strategies |
| Creditors | Financial stability monitoring | Debt covenants, repayment schedules | Maintain open lines of communication regarding financial performance |
| Customers | Product/service experience | Net promoter score, service usage | Ensure continuity of care and service quality during restructuring |
| Partners | Strategic alliances | Partnership performance | Reassess partnerships to ensure alignment with core business objectives |

---

## 4. Communication, Marketing & Execution Strategy

### Multi-Level Communication Strategy

- **Executive Leadership Communications:** Clearly articulate the turnaround strategy and financial health to stakeholders.
- **Investor Relations:** Provide transparent updates on financial performance and restructuring efforts.
- **Internal Communications:** Foster employee engagement through regular updates and involvement in cost-saving initiatives.
- **External Relations:** Maintain customer trust by ensuring service continuity and quality.

### Phased Execution Plan

- **Near-term (1-3 months):** 
  - Immediate cost-cutting measures.
  - Cash flow assessment and creditor negotiations.
  
- **Mid-term (4-6 months):** 
  - Implement operational efficiencies.
  - Monitor financial performance against revised forecasts.
  
- **Long-term (7-18 months):** 
  - Develop a sustainable growth strategy post-recovery.
  - Align stakeholder interests for future investments.

Each phase should have designated executive sponsors, success metrics, and risk mitigation strategies to ensure accountability and progress.

---

## 5. Investor Recommendation (Risk-Aware)

**Recommendation:** **Sell**. Given the company's current Z-Score of -4.683 and its position in the Distress Zone, it is advisable for investors to divest until the company demonstrates a clear turnaround strategy and improved financial health.

> “This is not financial advice—consult your financial advisor.”

---

## 6. External Stakeholder Bargaining Power

| Stakeholder Name / Type | Nature of Bargaining Power | Degree of Influence | Brief Rationale (Cited) |
| ----------------------- | -------------------------- | ------------------- | ----------------------- |
| Creditors | High | High | Creditors have significant influence due to the company's high leverage and need for restructuring. |
| Customers | Moderate | Moderate | Customer retention is crucial for revenue; however, they have limited influence over corporate decisions. |
| Shareholders | Moderate | High | Shareholders can exert influence through voting rights and market reactions to financial performance. |
| Employees | Low | Moderate | Employees can impact operational efficiency but have limited bargaining power in financial decisions. |

The bargaining power of creditors is particularly high given the company's financial distress, necessitating careful negotiation to secure favorable terms.

---

## 7. References and Data Sources

This analysis draws on financial data from sources such as SEC EDGAR/XBRL filings, Yahoo Finance, and company quarterly or annual reports. Market data was obtained from Yahoo Finance historical prices. All computations, including the Altman Z-Score, follow the methodology described by Altman (1968) with robust error handling. The analysis is part of the open-source Altman Z-Score Analysis project (https://github.com/fabioc-aloha/Altman-Z-Score), authored by Fabio Correa. Theoretical frameworks referenced (as applicable) include:
- Altman, E. I. (1968). “Financial Ratios, Discriminant Analysis and the Prediction of Corporate Bankruptcy.” *Journal of Finance*, 23(4), 589–609.
- Hofer, C. W. (1980). *Turnaround Strategies.*
- Bibeault, D. B. (1999). *Corporate Turnaround.*
- Hoskisson, R. E., White, R. E., & Johnson, R. A. (2004). *Corporate Restructuring.* 

---



---

# Appendix

## Raw Data Field Mapping Table (by Quarter)
| Quarter   | Canonical Field     | Mapped Raw Field                        | Value (USD millions)   |
|-----------|---------------------|-----------------------------------------|------------------------|
| 2025 Q1   | total_assets        | Total Assets                            | 583.7                  |
| 2025 Q1   | current_assets      | Current Assets                          | 331.4                  |
| 2025 Q1   | current_liabilities | Current Liabilities                     | 215.7                  |
| 2025 Q1   | retained_earnings   | Retained Earnings                       | -2,204.1               |
| 2025 Q1   | total_liabilities   | Total Liabilities Net Minority Interest | 247.6                  |
| 2025 Q1   | market_value_equity |                                         | 0.0                    |
| 2025 Q1   | ebit                | EBIT                                    | -1.3                   |
| 2025 Q1   | sales               | Total Revenue                           | 462.3                  |
| ---       | ---                 | ---                                     | ---                    |
| 2024 Q4   | total_assets        | Total Assets                            | 580.7                  |
| 2024 Q4   | current_assets      | Current Assets                          | 343.1                  |
| 2024 Q4   | current_liabilities | Current Liabilities                     | 213.5                  |
| 2024 Q4   | retained_earnings   | Retained Earnings                       | -2,202.8               |
| 2024 Q4   | total_liabilities   | Total Liabilities Net Minority Interest | 239.6                  |
| 2024 Q4   | market_value_equity |                                         | 0.0                    |
| 2024 Q4   | ebit                | EBIT                                    | -21.5                  |
| 2024 Q4   | sales               | Total Revenue                           | 337.0                  |
| ---       | ---                 | ---                                     | ---                    |
| 2024 Q3   | total_assets        | Total Assets                            | 653.0                  |
| 2024 Q3   | current_assets      | Current Assets                          | 432.7                  |
| 2024 Q3   | current_liabilities | Current Liabilities                     | 279.6                  |
| 2024 Q3   | retained_earnings   | Retained Earnings                       | -2,180.7               |
| 2024 Q3   | total_liabilities   | Total Liabilities Net Minority Interest | 310.8                  |
| 2024 Q3   | market_value_equity |                                         | 0.0                    |
| 2024 Q3   | ebit                | EBIT                                    | -8.8                   |
| 2024 Q3   | sales               | Total Revenue                           | 331.0                  |
| ---       | ---                 | ---                                     | ---                    |
| 2024 Q2   | total_assets        | Total Assets                            | 674.2                  |
| 2024 Q2   | current_assets      | Current Assets                          | 549.6                  |
| 2024 Q2   | current_liabilities | Current Liabilities                     | 324.5                  |
| 2024 Q2   | retained_earnings   | Retained Earnings                       | -2,171.6               |
| 2024 Q2   | total_liabilities   | Total Liabilities Net Minority Interest | 349.3                  |
| 2024 Q2   | market_value_equity |                                         | 0.0                    |
| 2024 Q2   | ebit                | EBIT                                    | 7.2                    |
| 2024 Q2   | sales               | Total Revenue                           | 356.3                  |
| ---       | ---                 | ---                                     | ---                    |
| 2024 Q1   | total_assets        | Total Assets                            | 671.8                  |
| 2024 Q1   | current_assets      | Current Assets                          | 552.7                  |
| 2024 Q1   | current_liabilities | Current Liabilities                     | 356.4                  |
| 2024 Q1   | retained_earnings   | Retained Earnings                       | -2,179.0               |
| 2024 Q1   | total_liabilities   | Total Liabilities Net Minority Interest | 379.3                  |
| 2024 Q1   | market_value_equity |                                         | 0.0                    |
| 2024 Q1   | ebit                | EBIT                                    | -22.4                  |
| 2024 Q1   | sales               | Total Revenue                           | 346.9                  |

All values are shown in millions of USD as reported by the data source.

